Cathie Wood's ARK Innovation Stocks Performance Guide: Recursion Pharmaceuticals (RXRX)
RXRX has no dividends.
Table and Chart of RXRX Performance
See what a $1,000 investment in RXRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RXRX Returns | |
|---|---|
| Start Date | May-28-2021 |
| Start Price | $26.36 |
| End Date | May-16-2024 |
| End Price | $9.51 |
| # Prices | 37 |
| Min Date | Apr-28-2023 |
| Min Price | $4.77 |
| Max Date | Jun-30-2021 |
| Max Price | $36.50 |
| Total Return | -63.92% |
| Annualized Return | -28.15% |
| Current Value of $1,000 Purchase | $361 |
| Number Returns | 666 |
| Average Return | -17.62% |
| Number Profitable Returns | 208 |
| Percent Profitable Returns | 31.23% |
| Number Unprofitable Returns | 458 |
| Percent Unprofitable Returns | 68.77% |
| Profitable to Unprofitable Returns Ratio | 0.45 |
| RXRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,278,627,000 |
| Beta | 0.848 | Price to Sales | 44.27 |
| Earnings per Share | $-1.6300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.263 |
| PRICE DATA | |
| 52 Week High | $16.75 |
| 52 Week Low | $4.97 |
| Analyst Target Price | $13 |
| 50-Day Moving Average | $9.27 |
| 200-Day Moving Average | $9.02 |
| FINANCIAL DATA | |
| Revenue per Share | $0.211 |
| Revenue | $46,235,000 |
| Profit Margin | 0% |
| Return on Equity | -85.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RXRX Compare Returns with S&P 500
RXRX Trendline Chart
RXRX Moving Average Chart
RXRX Stock Return Map - See Patterns of Gains and Losses
RXRX Stock Returns/Purchase Dates